Prongs or mask for nasal continuous positive airway pressure (CPAP) in preterm infants
Completed
- Conditions
- RespiratoryRespiratory distress of newborn
- Registration Number
- ISRCTN43000196
- Lead Sponsor
- The National Children's Research Centre (Ireland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1. Infants born less than or equal to 30 weeks' gestation by best obstetric estimate, either sex
2. Receive nasal CPAP using the Infant Flow Driver or SiPAP machine (Viasys, Yorba Linda CA, USA) in the neonatal intensive care unit
Exclusion Criteria
Infants with congenital anomalies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which nasal CPAP improves oxygenation in preterm infants with respiratory distress syndrome?
How does the effectiveness of nasal prongs compare to nasal masks in maintaining CPAP in preterm infants with respiratory distress syndrome?
What biomarkers are associated with successful CPAP outcomes in preterm infants with respiratory distress syndrome?
What are the potential adverse events of nasal CPAP in preterm infants and how are they managed in clinical practice?
How do combination therapies with surfactant and nasal CPAP via prongs or masks impact survival rates in preterm infants with respiratory distress syndrome?